3 Firms Build Alfasigma's Nearly $800M Intercept Pharma Buy
By Yeji Jesse Lee · September 26, 2023, 5:17 PM EDT
Italian pharmaceutical giant Alfasigma on Tuesday agreed to acquire U.S.-based Intercept Pharma, in an all-cash deal guided by three law firms and valued at $19 a share, or nearly $800 million....
To view the full article, register now.